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SP-B, a protein absolutely required to maintain the lungs open after birth, is synthesized in the pneumocytes as a precursor containing
C-terminal and N-terminal domains flanking the mature sequence. These flanking-domains are cleaved to produce mature SP-B, coupled
with its assembly into pulmonary surfactant lipid–protein complexes. In the present work we have optimized over-expression in
Escherichia coli and purification of rproSP-BΔC, a recombinant form of human proSP-B lacking the C-terminal flanking peptide, which is
still competent to restore SP-B function in vivo. rProSP-BΔC has been solubilized, purified and refolded from bacterial inclusion bodies in
amounts of about 4 mg per L of culture. Electrophoretic mobility, immunoreactivity, N-terminal sequencing and peptide fingerprinting all
confirmed that the purified protein had the expected mass and sequence. Once refolded, the protein was soluble in aqueous buffers.
Circular dichroism and fluorescence emission spectra of bacterial rproSP-BΔC indicated that the protein is properly folded, showing around 32% α-
helix and a mainly hydrophobic environment of its tryptophan residues. Presence of zwitterionic or anionic phospholipids vesicles caused changes in
the fluorescence emission properties of rproSP-BΔC that were indicative of lipid–protein interaction. The association of this SP-B precursor with
membranes suggests an intrinsic amphipathic character of the protein, which spontaneously adsorbs at air–liquid interfaces either in the absence or in
the presence of phospholipids. The analysis of the structure and properties of recombinant proSP-BΔC in surfactant-relevant environments will open
new perspectives on the investigation of the mechanisms of lipid and protein assembly in surfactant complexes.
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Pulmonary surfactant is a complex mixture of lipids and
proteins produced by type II pneumocytes. Surfactant is
secreted into the very thin aqueous layer that covers the
alveolar epithelium where it plays an essential role in reducingAbbreviations: CD, circular dichroism; DPPC, 1,2-dipalmitoyl-sn-glycero-
3-phosphocholine; IPTG, Isopropyl-β-D-thiogalactopyranoside; MLV, Multi-
lamellar vesicles; PBS, phosphate buffer saline; PMSF, phenylmethanesul-
phonyl fluoride; POPC, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine;
POPG, 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-rac-glycerol; SUV, Small
unilamellar vesicles; SAPLIP, Saposin-like protein; TB, Terrific Broth culture
medium; TEV, Tobacco etch virus
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doi:10.1016/j.bbamem.2006.07.016surface tension at the air–liquid interface to prevent alveolar
collapse at the end of expiration.
There are four specific pulmonary surfactant proteins called SP-
A, SP-B, SP-C and SP-D. The larger surfactant proteins, SP-A and
SP-D, are hydrophilic, while SP-B and SP-C are small very
hydrophobic polypeptides. Surfactant protein B is a homodimer,
containing 79 amino acids per monomer, which plays a key role in
pulmonary surfactant function. Reduction of alveolar SP-B
content causes surfactant dysfunction and respiratory failure
[1,2]. Mutations in the SP-B gene (SFTPB) that result in a
complete absence of the mature protein in the airways are
invariably fatal shortly after birth, demonstrating that SP-B is
absolutely required for postnatal lung function and survival [1,3,4].
Human SP-B is synthesized by type II pneumocytes as a
preproprotein of 381 amino acids. A signal peptide of 23
1622 A.G. Serrano et al. / Biochimica et Biophysica Acta 1758 (2006) 1621–1632residues (1–23) allows translocation of the precursor protein
into the endoplasmic reticulum (ER). Along the exocytic
pathway of type II cells proSP-B (24–381) is proteolytically
cleaved in at least three different steps [5,6]. Cleavage of the N-
terminal (24–200) and C-terminal (280–381) flanking domains
generates the biophysically active mature SP-B. This hydro-
phobic peptide is positively charged and has been shown to
promote aggregation, fusion and disruption of liposomes
containing negatively charged phospholipids [7–10]. All these
features make mature SP-B difficult to express as a recombinant
protein in heterologous systems. Lin and coworkers [11]
demonstrated that the N-terminal propeptide, consisting of the
mature peptide and the N-terminal flanking domain, is
necessary and sufficient for sorting and secretion of SP-B in
different mammalian cell lines [12]. Expression of the N-
terminal propeptide in SP-B knock-out mice completely
restored lung function and normal surfactant composition,
indicating that the C-terminal flanking domain is not required
for SP-B processing and survival [13]. Considering the intrinsic
hydrophobicity of mature SP-B and its propensity to interact
with lipids, the intracellular transport of this molecule likely
requires association with a hydrophilic chaperone-like element.
In fact, Lin et al. [11] previously proposed that the N-terminal
domain might fulfill this role, protecting SP-B from the
environment until the precise time and location where lipids
and proteins assemble.
ProSP-B is a transient intermediate in SP-B synthesis and
does not accumulate in type II pneumocytes. Isolation and
purification of this protein from natural sources in amounts
sufficient for its characterization is therefore not feasible. The
goal of the present work was to purify enough recombinant
human proSP-B (rproSP-BΔC) from a prokaryote expression
system (E. coli) to initiate a detailed characterization of its
structure and lipid-interacting properties.
2. Materials and methods
2.1. Expression, purification and refolding of rproSP-BΔC
The cDNA sequence coding for proSP-BΔC (amino acids 24–381;
GenBank® accession No. M24461, including mutations described in Fig. 1)Fig. 1. Sequence of rproSP-BΔc protein. The N-terminal sequence of the recombinan
virus (TEV) protease cleavage site to eventually remove the His-tag. A hydroxylamin
the double substitution Q205N/F206G. An endogenous hydroxylamine cleavage sitwas cloned into the EcoRI–XbaI sites of the bacterial expression vector pProEx-
1 [14] (Life Technologies, Gaithersburg, MD, USA) (construct provided by Dr.
T.E. Weaver, Cincinnati Children's Hospital Medical Center, Cincinnati, OH,
USA). The sequence of the insert was confirmed by DNA sequencing and
Escherichia coli UT5600 was transformed with this plasmid for expression.
Fig. 2 presents a scheme outlining the main steps of the strategy optimized to
produce recombinant soluble proSP-BΔC in bacterial cultures. A single colony of
E. coliUT5600 transformedwith pProEx-1/proSP-BΔC plasmid (Fig. 3) was first
grown overnight at 37 °C in 20 mL of LB medium containing 100 μg/mL
ampicillin. The culture was then inoculated into 1 L of TB medium containing
100 μg/mL ampicillin and was grown to an OD600 nm of 0.6–0.8. Induction was
then performed by addition of IPTG to a final concentration of 0.25 mM. The
culture was grown overnight at 37 °C and harvested by centrifugation at 5500×g
for 20 min at 4 °C. The bacterial pellet was suspended in a volume of buffer A
(50 mM sodium phosphate buffer, pH 7, containing 300 mM NaCl) equal to ten
times its weight, and frozen until required. Cells were disrupted by incubation of
the bacterial suspension for 20 min in the presence of 1 mg/mL lysozyme,
0.1 mM PMSF and 10 mM β-mercaptoethanol at room temperature, followed by
tip sonication (2×2 min) in a digital sonifier II W-250 (Branson Ultrasonics,
Danbury, CT, USA). After centrifugation for 20 min at 12,000×g and 4 °C, the
pellet of inclusion bodies was resuspended for solubilization in a volume equal to
10 times its weight of buffer B (50 mM sodium phosphate, pH 7, 300 mMNaCl,
10 mM β-mercaptoethanol, 8 M urea) and sonicated (2×2 min). After overnight
shaking at 4 °C the suspension was sonicated again and clarified by
centrifugation for 20 min at 15000×g. The supernatant was applied to a 2 mL
(bed volume) TALON™metal affinity column (Clontech, Palo Alto, CA, USA).
Chromatography was performed under denaturing conditions, as described by
the supplier. Briefly, the columnwaswashed twice with buffer B, the second time
in the presence of 5 mM imidazole. rProSP-BΔC was eluted with buffer B
containing 200mM imidazole. Denaturing reagents and the other chemicals were
eliminated from the eluates by successive dialysis at 4 °C to promote proper
folding of the protein. Sequential dialysis was performed with the following
buffers: buffer C, 50 mM sodium phosphate, pH 7, 150 mM NaCl, 10 mM β-
mercaptoethanol, 5 M urea; buffer D, 50 mM sodium phosphate, pH 7, 150 mM
NaCl, 10 mMβ-mercaptoethanol, 1M urea; buffer E, 50 mM sodium phosphate,
pH 7, 300 mM NaCl; buffer F, 5 mM Tris, 150 mM NaCl, pH 7. Following
dialysis, the protein solution was aliquoted and stored at −80 °C.
2.2. Electrophoresis and Western blot analysis
Sodium dodecylsulfate-polyacrylamide gel electrophoresis was performed
using 12% and 4% acrylamide in the separating and stacking gels, respectively.
Unless otherwise indicated, electrophoresis was performed under reducing
conditions in the presence of 5% β-mercaptoethanol. Gels were stained with
Coomassie brilliant blue R-250 (Applichem, Darmstadt, Germany). Alterna-
tively, proteins were transferred to nitrocellulose membranes using a semidry
transfer cell (Bio-Rad Laboratories, Hercules, CA, USA) set at 15 V for 25 min.
Nitrocellulose membranes were blocked overnight at 4 °C in PBS containingt protein includes a His6-tag and a spacer region followed by the Tobacco etch
e cleavage site (NG) is present at the beginning of the SP-B mature sequence by
e was eliminated by the additional amino acid substitution N139Q.
Fig. 3. Structure of pProEx-1/proSP-BΔC, the expression plasmid of rproSP-
BΔC. The construct encoding a processing intermediate of human pulmonary
surfactant protein B (GenBank® Accession No. M24461) proprotein, including
the N-terminal propeptide and the mature protein (amino acids 24–279), is
cloned between the EcoRI–XbaI restriction sites of pProEx-1 vector (Life
Technologies, Gaithersburg, MD, USA). pProEx-1 vector includes a reiterative
cytosine, adenosine, thymidine sequence at the 5′ end of the multicloning
cleavage site (MCS) resulting in the incorporation of 6 His at the NH2-terminus
of the recombinant protein. The vector also contains the cleavage site for TEV
protease to eventually remove the His-tag from the fusion protein. The
tryptophan lactose hybrid promoter Trc promoter and the lacIq gene preceding
the ribosome binding site (RBS) allow high level of expression of the
recombinant protein and tight regulation using IPTG.
Fig. 2. Flow chart diagram of the procedure optimized to express, purify and
refold rproSP-BΔC from bacterial cell cultures.
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was done using PBS containing 0.05% Tween-20 and 1.5% non-fat dried
milk, for 2 h, at room temperature. Following washing with PBS containing
0.1% Tween-20, the membranes were incubated for another 2 h with the
secondary antibody (peroxidase-conjugated) and washed again. The immuno-
blot was developed using luminol (Sigma, St. Louis, MO, USA) as a
substrate for the chemiluminescent reaction. The primary antibodies used
were an anti-His-tag peroxidase-conjugated monoclonal antibody (Sigma) or
an anti-proSP-B monoclonal antibody, generously provided by Dr. T. E.
Weaver (Cincinnati Children's Hospital Medical Center, Cincinnati, OH,
USA). In the latter case, the secondary antibody was anti-mouse IgG
peroxidase-conjugated (Sigma).
2.3. Protein analysis
Amino acid analysis of hydrolyzed rproSP-BΔC aliquots was performed on a
Beckman 6300 automatic analyzer to accurately determine the protein
concentration.
The NH2-terminal sequence of rproSP-BΔC was determined by automated
Edman degradation. After SDS-PAGE the protein was transferred to a
polyvinylidene difluoride membrane (PVDF, BioRad, Richmond, CA, USA).
Protein bands were identified by Coomassie blue staining, excised and
microsequenced using a Procise 494 sequencer from Applied Biosystems.
2.4. Mass spectrometry analysis of protein spots
The gel spots of interest were manually excised from micro preparative gels
using biopsy punches. Proteins selected for analysis were reduced in-gel,
alkylated and digested with trypsin according to Sechi and Chait [15]. Briefly,
spots were washed twice with water, shrunk 15 min with 100% acetonitrile anddried in a Savant SpeedVac for 30 min. Then the samples were reduced with
10 mM dithiotreitol in 25 mM ammonium bicarbonate for 30 min at 56 °C and
subsequently alkylated with 55 mM iodoacetamide in 25 mM ammonium
bicarbonate for 20 min in the dark. Finally, samples were digested with 12.5 ng/
μl sequencing grade trypsin (Roche Molecular Biochemicals, Mannheim,
Germany) in 25 mM ammonium bicarbonate (pH 8.5) overnight at 37 °C. After
digestion, the supernatant was collected and 1 μl was spotted onto a MALDI
target plate and allowed to air-dry at room temperature. Then, 0.4 μl of a 3 mg/
ml of α-cyano-4-hydroxy-transcinnamic acid matrix (Sigma) in 50% acetonitrile
was added to the dried peptide digest spots and allowed again to air-dry at room
temperature. MALDI-TOF MS analyses were performed in a Voyager-DE-
TM STR instrument (PerSeptives Biosystems) fitted with a 337 nm nitrogen laser
and operated in reflector mode with an accelerating voltage of 20000 V. All mass
spectra were calibrated externally using a standard peptide mixture (Sigma).
Peptides from the auto digestion of trypsin were used for the internal calibration.
The analysis by MALDI-TOF mass spectrometry produces peptide mass
fingerprints and the peptides observed can be collated and represented as a list of
monoisotopic molecular weights. Data were collected in the m/z range of 700–
2500. MS/MS sequencing analyses were carried out using the MALDI-tandem
time-of flight mass spectrometer 4700 Proteomics Analyzer (Applied
Biosystems, Framingham, MA).
2.5. Quantitation of free –SH groups
The presence of sulfhydryl (SH) groups in rproSP-BΔC was analyzed by
using Ellman's reagent, 5,5′-dithiobis(2-nitrobenzoic acid) (DTNB) [16,17], in
the absence or in the presence of 5 M guanidinium chloride. Ten-μg aliquots of
rproSP-BΔC were incubated for 30 min at room temperature in 5 mM Tris buffer
pH 8, containing 150 mM NaCl with or without 5 M guanidinium chloride.
DTNB was then added to a concentration of 12.2 μM or 8.2 μM (final volume
Fig. 4. Western blot analysis of rproSP-BΔC protein expressed after
induction with IPTG. E. coli cells transformed with pProEx-1/proSP-BΔC
before (lane 1) and after 0.5, 1, 2 or 3 h (lanes 2–5, respectively)
induction with IPTG. Western blot was performed using mouse anti-His tag
monoclonal antibodies (peroxidase-conjugated). The electrophoretic mobility
of the detected major band was consistent with the expected molecular
mass of rproSP-BΔC (31–32 kDa).
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measurements were interpolated in a calibration curve previously prepared from
data of samples with different concentrations of free Cys in the same conditions
described above.
2.6. Circular dichroism
Far-UV circular dichroism (CD) spectra were obtained in a Jasco-715
spectropolarimeter equipped with a xenon lamp [18]. The protein concentra-
tion was 0.1 mg/mL and the optical path length 0.1 cm. The CD spectra of
the protein in membrane environments was obtained in the presence of
unilamellar vesicles of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
(POPC) or 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-rac-glycerol (POPG),
selected as representative of zwitterionic and anionic membranes, respec-
tively, and because these species are easily dispersed at 25 °C. The
contribution of the buffer, as well as that of the phospholipid vesicles, when
present, was always subtracted. A minimum of four spectra were accumulated
for each sample. Values of mean residue ellipticity were calculated on the
basis of 110 as the mean molecular weight per residue and are reported in
terms of [θ] (degrees×cm2×dmol−1). The secondary structure of the protein
was evaluated by computer fit of the dichroism spectrum into four simple
components (α-helix, β-sheet, turns and random coil) using the CDPro
software package containing three commonly used programs: SELCON3,
CONTIN/LL and CDSSTR [19,20]. This software allows the use of different
sets of proteins to increase the reliability of analyses of membrane-interacting
proteins, which is probably the case for highly lipophilic SP-B polypeptide.
2.7. Fluorescence emission spectroscopy
Tryptophan fluorescence emission spectra of rproSP-BΔC were recorded in a
SLM-Aminco AB-2 spectrofluorimeter. The contribution of the buffer, as well
as that of the phospholipid vesicles, when present, was always subtracted.
Excitation wavelength was set at 275 nm or 295 nm and emission spectra were
measured over the range of 300–440 nm. Both the excitation and emission slits
were set at 4 nm. The contribution of tyrosine to the emission spectra was
calculated, as previously described elsewhere [21], by subtracting the emission
spectra measured at λexc=295 (multiplied by a normalizing factor) from the
emission spectra measured at λexc=275 nm. This factor is the ratio between the
fluorescence intensities measured with λexc=275 nm and λexc=295 nm at the
emission wavelength of 380 nm, where no Tyr contribution is expected.
2.8. Preparation of phospholipid vesicles
Vesicles made of 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC),
POPC or POPG were prepared by hydrating dry lipid films in a 5 mM Tris,
5 mM Mes and 5 mM sodium acetate buffer, pH 7, containing 150 mM NaCl,
and allowing them to swell for 1 h at room temperature (for POPC and POPG) or
at 50 °C (for DPPC) with continuous shaking. This treatment typically produces
multilamellar phospholipid suspensions (MLV). To obtain small unilamellar
vesicles (SUV), the lipid suspensions were sonicated on ice (for POPC and
POPG) or in a water bath at room temperature (for DPPC) using a Branson
UP200s tip sonifier set at 360 w/cm2, making cycles of 0.5 s for 2 min.
Samples containing phospholipid vesicles and rproSP-BΔC (used to analyze
the effects of lipids in the circular dichroism or fluorescence spectra of the
protein) were prepared by injection of the appropriate amount of protein into the
phospholipid vesicle suspension followed by 10 min incubation at 37 °C.
2.9. Interfacial adsorption of rproSP-BΔC
Adsorption of rproSP-BΔC to an open air–liquid interface was assayed using
a specially designed surface balance as previously described [22]. The
microbalance was filled with 1.5 mL of buffer (Tris 5 mM, NaCl 150 mM,
pH 7) and, after 5 min equilibration, 30 μL of buffer containing 11 μg of protein
were injected into the subphase. Changes in surface pressure (π) were then
monitored over time. The subphase was continuously stirred and the trough was
thermostated at 25 °C. Subphases were always prepared with double distilled
water (the second distillation performed in the presence of potassiumpermanganate). Injection of equivalent volumes of buffer did not produce any
detectable change in surface pressure.
2.10. Interaction of rproSP-BΔC with preformed phospholipids
monolayers
Association of rproSP-BΔC with phospholipid monolayers, preformed at
different initial surface pressures (πi), was followed (in the same microbalance
mentioned above) by monitoring changes in surface pressure (Δπ) over time
once the protein had been injected into the subphase (Tris 5 mM, NaCl 150 mM,
pH 7, in double distilled water). Phospholipid monolayers were formed by
spreading a concentrated solution of the lipids (typically DPPC:POPG, 7:3, w/
w) in chloroform:methanol (3:1, v/v) on top of the aqueous surface. After 10 min
equilibration, 11 μg of protein were injected into the subphase. The highest
increment in surface pressure (Δπ) after protein injection was plotted vs. the
initial pressure (πi) of the monolayer, allowing calculation of the critical
insertion pressure (πc), defined as the maximum π at which the protein can still
insert. The subphase was continuously stirred and the temperature was kept
constant at 25 °C during the experiment.3. Results
3.1. Expression, purification and refolding of pro-SP-BΔC
Expression of recombinant proSP-BΔC containing an N-
terminal His6-tag was carried out in TB media and induced by
the addition of IPTG as described under Materials and
methods. The sequence of the recombinant protein expressed
is depicted in Fig. 1. In order to eventually separate mature
SP-B from the N-terminal propeptide in future studies, a
hydroxylamine cleavage site (N205G206) was inserted at the
beginning of the mature sequence in place of the original QF
pair in the sequence of wild type proSP-B. Chemical cleavage
at this site should in principle produce a SP-B-like
polypeptide with exactly the same length than native SP-B
but having glycine instead of wild-type phenylalanine at the
N-terminal end. The effect of this substitution for the surface
activity of recombinant SP-B forms has to be established. A
further additional single amino acid substitution eliminated an
endogenous hydroxylamine cleavage site (N139Q). Fig. 4
clearly shows the time-dependent appearance of a protein
band with an apparent molecular mass corresponding to that
of the proSP-BΔC (31.8 kDa), and a minor band with
apparent higher mobility, following IPTG induction. The
recombinant protein accumulated in bacterial cells leading to
the formation of inclusion bodies. Fig. 5 (a and b) shows the
Fig. 5. Expression of rproSP-BΔC in E. coli. (a) SDS-PAGE analysis of UT5600 cells transformed with pProEx-1/proSP-BΔC before (lane 1) and after (lane 2) O/
N induction. The electrophoresis was run under reducing conditions and the gels were stained with Coomassie blue. (b) Western blot analysis using an anti-
proSP-B antibody of the same samples loaded in the Coomassie stained gel in panel a. (c) Coomassie blue stain SDS-PAGE analysis of rproSP-BΔC produced
after O/N induction of bacteria. Cultures were harvested and centrifuged to eliminate the media. Cells were then resuspended in sodium phosphate buffer pH 7,
containing NaCl 300 mM. After incubation in the presence of lysozyme and sonication, cells lysate were centrifuged to separate the pellet of inclusion bodies
(lane 1) from the supernatant (lane 2). (d) Western blot analysis using an anti-proSP-B antibody of the same samples loaded in the Coomassie stained gel in panel
c. Arrows indicate the position of rproSP-BΔC, which has an expected molecular mass of ∼31.8 kDa.
Fig. 6. SDS-PAGE and Western blot analysis of purified, refolded rproSP-BΔC.
(a) 12% acrylamide gel stained with Coomassie blue. Lane 1, molecular
markers; lane 2, 6 μg of purified rproSP-BΔC. (b) Western blot of rproSP-BΔC
transferred to a nitrocellulose membrane from a 12% acrylamide gel and probed
with anti-proSP-BΔC monoclonal antibody. Arrows indicate the position of
rproSP-BΔC monomer (∼31 kDa) and three minor peptides presumably
resulting from degradation of the recombinant protein. The molecular mass of
standard markers is indicated on the left of each panel.
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BΔC transformed UT5600 cells before and after O/N
induction. A single band of recombinant protein, with an
electrophoretic mobility corresponding to the expected
molecular mass of a monomer of rproSP-BΔC, was detected
by Western Blot analysis. The same band can be distin-
guished in the Coomassie blue stained gel. No rproSP-BΔC
band was detected prior to IPTG induction.
Isolation of inclusion bodies from bacteria pellets was
performed as described under Materials and methods. After
cell lysis using tip sonication and subsequent centrifugation,
aliquots of the supernatant and the resuspended pellet were
analyzed by 12% acrylamide gel electrophoresis. Most of
the protein remained in the pellet of inclusion bodies after
centrifugation as can be observed in Fig. 5 (c and d). A
certain fraction of the protein was now observed to form
dimers and oligomers of higher molecular mass, even
though the main fraction migrated as a monomer. rProSP-
BΔC was then purified by solubilization of inclusion bodies
in 8 M urea followed by a metal affinity chromatography
under denaturing conditions. The purified protein fractions
were extensively dialyzed under progressively less denatur-
ing conditions, as outlined in Materials and methods, to
remove excess imidazole and to refold the protein. No
visible precipitate was observed during dialysis, indicating
that rproSP-BΔC is soluble at micromolar concentrations
under these conditions. The purified and refolded protein
was analyzed by 12% acrylamide gel electrophoresis
followed either by Coomassie blue staining or Western
blot analysis (Fig. 6). SDS-PAGE of purified rproSP-BΔC
detected a single band after Coomassie blue staining,
corresponding to the electrophoretic mobility of proSP-BΔC
monomer. This mobility is slightly higher than that of most
of the protein in the intact cells (see Fig. 4), probably as a
consequence of the formation of some intramolecular
disulphides (see below), once the protein is exposed to apartially oxidant environment, outside the cells. Western blot
analysis also detected three minor bands with higher
electrophoretic mobility than that of the putative recombi-
nant protein band. All bands were detected using an anti-
proSP-B monoclonal antibody as well as an anti-polyhisti-
dine monoclonal antibody (not shown) suggesting that the
three minor bands resulted either from partial degradation or
incomplete translation of the recombinant protein. Mass
spectrometry analysis of all protein spots from gel electro-
phoresis (not shown) confirmed this hypothesis. Densito-
metric analysis from Coomassie blue stained gels estimated
that approximately 70–75% of the purified protein consisted
of the species with apparent molecular mass of 31 kDa. Any
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than 10% of the total mass of the purified protein. A final
gel filtration chromatography step over Sephadex G-75
(Amersham Pharmacia Biotech) was performed to ensure
complete sample homogeneity, but only a single protein
peak was detected in the elution profile. All the protein
mass eluted in fractions corresponding to the exclusion
volume of the column, suggesting that the concentration step
of protein samples required for chromatography application
likely promotes protein–protein interactions, leading to the
formation of aggregates. Structural characterization of
rproSP-BΔC was therefore approached using the protein as
obtained after refolding dialysis. Following the purification
procedures described above, approximately 4 mg of highly
pure rproSP-BΔC were obtained per liter of culture.
Quantitation of purified protein was initially achieved by
amino acid analysis. The absorption spectrum of different
quantified samples of purified protein allowed determination ofFig. 7. Peptide mass fingerprint of rproSP-BΔC. (a) The peptide mixture resulting from
methods, was subjected to MALDI-TOFmass spectrometry. Data were collected in th
mass was calculated taking into account the indicated modifications. (b) Sequence of r
identified peptides are shaded or included in a box (when overlapping). The theoretica
glutamine hydrolysis to yield glutamic acid. Cys_CAM: cysteine reacted with iodo
polyacrylamide adducts. MSO: methionine in oxidized form. * This peptide requires
since this enzyme usually cleaves after basic residues not followed by proline.the molar extinction coefficient of rproSP-BΔC at 280 nm,
e280 ¼ ð3:47F0:15Þ  104M1cm1
3.2. Characterization of purified recombinant rproSP-BΔC
Mass spectrometry and peptide fingerprinting analysis from
the SDS-PAGE band corresponding to the putative rproSP-BΔC
monomer allowed identification of 10 peptides covering the
major part of the amino acid sequence of the protein (Fig. 7).
Almost all the predicted tryptic peptides with molecular masses
falling in the analyzed m/z range (700–2500) were found in the
peptide mass fingerprint of rproSP-BΔC. Only the mass of one
theoretical peptide, covering the amino acid sequence of the
segment 258–269 (YSVILLDTLLGR), did not match any of
the masses of the peaks in the spectrogram. On the other hand,
the mass expected for the sequence 181–193 matched withthe in-gel digestion of rproSP-BΔC by trypsin, as described under Materials and
em/z range of 700–2500. Matched peptides are listed in the table. The theoretical
proSP-BΔC, indicating the theoretical trypsin cleavage sites. The sequence of the
l masses taking into account the known modifications are also indicated. Q→E:
acetamide to yield carboxyamidomethyl cysteine. Cys_PAM: cysteine forming
trypsin cleavage between RP, which is not an expected cleavage site for trypsin
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experimental masses obtained after mass spectrometry analysis,
even though the corresponding peptide would be the result of an
exceptional cleavage with trypsin after an arginine residue
followed by proline. As the NH2-terminal region of rproSP-BΔC
does not contain any tryptic peptide with expected molecular
mass within the analyzed m/z range, the NH2-terminal sequence
of the purified protein was determined by automated Edman
degradation, confirming up to 7 residues the expected N-
terminal sequence: M–G–H–H–H–H–H.
Taking into account that disulfide bonds are poorly
formed in the cytosol of E. coli and that the isolation and
purification procedure used to produce rproSP-BΔC was
carried out in the presence of β-mercaptoethanol, we wanted
to know whether or not the protein could form disulfide
bonds during or after refolding. To address this question we
optimized the determination of free Cys in rproSP-BΔC by
reaction with DTNB and subsequent spectrophotometric
detection under native and denaturing conditions. ProSP-
BΔC contains 17 cysteines, 7 within the sequence of the
mature peptide and 10 in the N-terminal fragment of the
recombinant protein. In the absence of denaturing agents
only 11–12% of the cysteines reacted with DTNB, indicating
that a major fraction of the cysteines were not accessible to
the reagent under these conditions. However, in the presence
of 5 M guanidinium chloride, the reaction with Ellman
reagent determined that practically 80% of the cysteines
remained as free Cys (–SH). Free cysteines were therefore
almost completely shielded from access to the reagent in the
folded protein.
The spectroscopic characterization of purified rproSP-BΔC is
shown in Fig. 8. The far-UV CD spectrum shows 2 minima in
ellipticity at ∼210 and ∼222 nm, indicative of a main α-helical
secondary structure (Fig. 8a). The estimation of different
secondary structure elements according to Selcon3, CDsstr andFig. 8. Spectroscopic characterization of rproSP-BΔC. (a) Far-UVcircular dichroism sp
protein concentration was 0.1 mg/mL. The solid line represents the theoretical spect
rproSP-BΔC were calculated from its far-UVCD spectrum using three different progra
SD. (b) Fluorescence emission spectrum of rproSP-BΔC in the same buffer. The protein
arbitrary units (au). The solid line represents the spectrum obtained upon excitation at 2
tyrosines to the global spectrum, calculated as described under Materials and methodContin programs resulted in the averaged values presented in
the table of Fig. 8a. As expected, the calculated proportion of α-
helix (∼32%) is the main contribution to the ordered secondary
structure according to the three methods of CD analysis
employed.
The tertiary structure of the protein in the environment of the
fluorophores was analyzed by fluorescence emission spectro-
scopy of the 6 tyrosines and 4 tryptophans contained in the
sequence of rproSP-BΔC (Fig. 8b). Upon excitation at 275 nm
the spectrum exhibited an emission maximum centred at
333 nm, shifted more than 15 nm from the position of the
maximum described for free tryptophan in aqueous solution
(348–350 nm) [23]. This indicates that the averaged micro-
environment of the tryptophans in rproSP-BΔC, probably
provided by protein folding, is significantly more hydrophobic
than that of a residue completely exposed to the solvent. This
blue-shift of the fluorescence, together with the circular
dichroism spectrum, supports the idea that the protein is
properly refolded after dialysis. Moreover, emission spectra
obtained upon excitation at 275 and 295 nm are practically
identical, indicating an almost negligible contribution of
tyrosines to the fluorescence spectrum of the protein. This
contribution, lower than expected for a Trp:Tyr ratio of 4:6 is
probably due to extensive resonance energy transfer from
tyrosine fluorescence to nearby tryptophans and/or to quench-
ing by other close side chains.
In order to verify that the introduction of a hydroxylamine
cleavage site at the beginning of the mature SP-B sequence as
well as the elimination of the endogenous hydroxylamine
cleavage site in the N-terminal propeptide (see Fig. 1) did not
affect the native structure of proSP-BΔC, a new construct
without any substitution with respect to the wild type DNA
sequence of proSP-BΔC was cloned and expressed in E. coli.
Isolation and purification of the protein was performed using the
same procedure described above, and its far-UV CD andectrumof rproSP-BΔC in 5mMTris buffer pH 7 containing 150mMofNaCl. The
rum calculated with CONTIN program [19]. Percents of secondary structure of
ms (Selcon 3, CDsstr and Contin/ll). Results are expressed in the table as means±
concentration was∼10 μg/mL and the fluorescence intensity (FI) is presented in
75 nm. Dotted lines represent the deconvoluted contributions of tryptophans and
s.
Fig. 10. Far-UV circular dichroism spectrum of rproSP-BΔC in the presence of
phospholipid vesicles. The spectra were obtained in the presence of POPC or
POPG unilamellar vesicles in 5 mM Tris, 5 mM Mes and 5 mM sodium acetate
buffer, pH 7, containing 150 mM of NaCl. The protein concentration was
0.1 mg/mL and the protein to lipid ratio, 1:4 (by weight).
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those shown in Fig. 8 (see supplementary data).
Following structural characterization, we analyzed the ability
of soluble refolded rproSP-BΔC to interact with phospholipid
membranes. Changes in Trp fluorescence emission of samples
containing rproSPBΔC in the presence of increasing amounts of
phospholipid vesicles are presented in Fig. 9. The analysis was
carried out in the presence of DPPC (the major lipid component
in pulmonary surfactant) as well as in the presence of
unsaturated zwitterionic (POPC) or anionic (POPG) phospho-
lipid vesicles. In all cases, a saturable increase in fluorescence
intensity observed in the presence of increasing concentrations
of lipid, indicates that rproSP-BΔC is able to interact with
membranes of all the three phospholipid species analyzed.
The secondary structure of the protein was also studied in the
presence of unilamellar vesicles of POPC or POPG by circular
dichroism (CD) (Fig. 10). Both spectra exhibit CD features
consistent with a mainly α-helical conformation, in similar
proportions to that estimated for the protein in the absence of
lipids. However, scattering problems with lipid-containing
samples did not allow obtaining CD spectra with good enough
signal-to-noise ratio at wavelengths lower than 200 nm, thus
preventing a reliable determination of the different secondary
structure proportions.
The intrinsic amphipathic structure of rproSP-BΔC is
revealed by its tendency to spontaneously adsorb to an air–Fig. 9. Fluorescence analysis of the interaction of rproSP-BΔC with phospholipid me
line) or in the presence of DPPC (squares), POPC (circles) or POPG (triangles) unilam
containing 150 mM of NaCl. The protein concentration was ∼10 μg/mL and the li
intensity (FI) at 333 nm of rproSP-BΔC on the concentration of the phospholipids. F
protein exhibits the maximum FI.liquid interface. Injection of an aliquot of the protein in a surface
balance is followed by an immediate increase in surface
pressure (Fig. 11a), to reach surface pressures around 20 mN/m.
This maximum pressure was achieved with peptide concentra-
tions of 0.2 μM or higher. Recombinant proSP-BΔC was alsombranes. (a) Fluorescence emission spectra of rproSP-BΔC in the absence (solid
ellar vesicles in 5 mM Tris, 5 mM Mes and 5 mM sodium acetate buffer, pH 7,
pid concentration was 50 μg/mL. (b) Dependence of the fluorescence emission
/F0 represents the relative fluorescence intensity measured at 333 nm, where the
Fig. 11. Interfacial adsorption/insertion of rproSP-BΔC. (a) Interfacial adsorption
kinetics of rproSP-BΔC to a clean air–liquid interface (dashed line) or to a
preformed DPPC:POPG, (7:3, w/w) monolayer (solid line), from a buffered
subphase (5 mM Tris, pH 7, containing 150 mM NaCl). After ∼5 min
equilibration, 30 μL of buffer containing 11 μg of protein (0.23 μM, final
concentration in the subphase) were injected into the subphase and changes in
surface pressure were monitored. The experiments were run at 25 °C with
continuous stirring of the subphase. (b) Increment of surface pressure (Δπ)
observed in preformed DPPC:POPG (7:3, w/w) monolayers measured 23 min
after injection of rproSP-BΔC (11 μg) into the subphase, plotted vs. the initial
surface pressure of the films (πi). The critical insertion pressure (πc) was
calculated by extrapolation of the plot at Δπ=0 mN/m.
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by a DPPC:POPG (7:3, w/w) monolayer. Fig. 11a shows the
insertion kinetics of the protein into a phospholipid monolayer
preformed at 13.5 mN/m. Injection of rproSP-BΔC is followed
by a rapid pressure increase (Δπ) as a consequence of the
association of the protein with the interfacial film. The observed
Δπ indicated association with, and eventual insertion of the
protein into the monolayer. In Fig. 11b, the increase in surface
pressure (Δπ) after injection of rproSP-BΔC has been plotted vs.
the initial surface pressure (πi) of different preexisting DPPC:
POPG (7:3, w/w) monolayers. As expected, Δπ decreased with
increasing πi, since tighter lipid packing prevents insertion of
the protein into the monolayer. From these plots one can
calculate the critical insertion pressure (πc), defined as the
maximum pressure at which the protein is still able to insert.
The resulting πc for rproSP-BΔC, under the experimental
conditions described above, was 21.3 mN/m. This parameter
depends on the monolayer composition as well as on the
relative affinity of the protein to associate with the interface
film. It is generally assumed that the lateral packing in a lipid
bilayer can be roughly mimicked by a monolayer compressedto ∼30 mN/m. Accordingly, molecules inserting against πc
values higher than 30mN/m are usually considered competent to
insert into lipid membranes [24], although the real lateral
pressure and lipid packing of a free-standing membrane is a
matter of discussion. A shallow membrane–protein association
can still be possible when πc values fall below this theoretical
threshold of 30 mN/m, as seems to be the case for rproSP-BΔC.
4. Discussion
ProSP-B, the precursor of pulmonary surfactant protein B, is a
protein intermediate that cannot be isolated from natural sources
in reasonable amounts to permit detailed analysis of structure and
behaviour under physiologically-relevant conditions. The
unprocessed precursor protein contains three well-defined
domains sharing a common disulfide bond pattern that relates
them to the saposin-like family of proteins (SAPLIP) [25]. The
most extensively studied of these domains is the one correspond-
ing to mature SP-B. The two flanking domains have also been
identified as saposin-like domains and different authors have
suggested the possibility of an independent function for each of
these domains after proSP-B proteolytic processing
[11,13,26,27]. One method to study proSP-B and its N- and C-
terminal domains is the production of each of the domains as
recombinant proteins in a heterologous system. ProSP-B (full
length) and shorter forms (including a protein without the C-
terminal flanking domain, SP-BΔC) have been expressed in
mammalian cell lines [11,12] to elucidate the structural
requirements for intracellular transport and targeting of SP-B
along the exocytic pathway of type II pneumocytes. More
recently, these recombinant precursor forms have been expressed
and purified from E. coli or insect cells for use as substrates to
identify proteases involved in proSP-B processing in vivo [6,28].
Expression and purification of theN- andC-terminal propeptides
of proSP-B have also been optimized in order to produce
antibodies against these particular domains [29]. In addition,
Zaltash and Johansson expressed and purified the SP-B precursor
from E. coli to get information on the secondary structure and
domain organization of the full length protein [25]. The latter is,
to our knowledge, the only published work addressing some
structural characterization of proSP-B.
Previous studies demonstrated that the N-terminal flanking
domain and the mature peptide are sufficient to mediate
appropriate targeting and processing of SP-B in type II cells
in vivo [12]. Moreover, transgenic mice expressing the
truncated form of proSP-B that lacked the C-terminal domain,
in a null background (SP-B−/−), survived without any evidence
of respiratory problems, having normal lung function and
properly processed SP-B in alveolar airspaces [13]. The goal of
the present study was to express, purify and characterize the
structure and lipid–protein interactions of this truncated form of
the SP-B precursor (rproSP-BΔC). The gene introduced was
engineered to have in the future the possibility to cleave and
separate afterwards the N-terminal propeptide from the mature
protein.
E. coli is one of themost frequently used organisms to produce
recombinant proteins because it is relatively inexpensive and
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formation usually does not take place under reducing
intracellular conditions, other SAPLIPs have been expressed
in this prokaryotic system yielding active proteins after
purification [30]. In addition, we have previously demonstrated
that the structure, lipid–protein interactions and surface activity
of an extensively reduced and alkylated form of the mature
peptide (SP-Br) were all similar to the features of native SP-B
purified from animal lungs. These antecedents suggest that a
recombinant form of mature SP-B, even in the absence of
disulfide bridges, could mimic most of the SP-B activities [22].
Recombinant proSP-BΔC has been purified from the
insoluble fraction of inclusion bodies in a single chromato-
graphic step, using a metal affinity column followed by
successive dialysis to facilitate protein refolding. Direct elution
of the protein from the metal affinity column in the absence of
urea was previously proposed as a method to obtain folded
rproSP-BΔC [31]. However, elution in urea-free buffer of the
high loads of protein used in the present work produced
irreversible stacking of the protein in the affinity matrix. By
refolding the eluted protein through stepwise dialysis, we could
produce about 4 mg of folded proSPBΔC per liter of culture.
Anti-proSP-B monoclonal antibody recognition, peptide mass
fingerprinting and N-terminal sequencing verified that the
purified protein had the expected features of proSP-BΔC.
According to the circular dichroism spectrum, purified
refolded rproSP-BΔC contained a high content of ordered
secondary structure including extensive α-helical structure
(∼32%). A similar content of α-helix (∼35%) was previously
estimated for proSP-B, the full length precursor of SP-B [25]
also expressed in E. coli. The structure of the saposin-like
domains has been previously addressed by CD analysis of
different SAPLIPs including NK-lysin, saposins A, B, C and
D, or mature SP-B. All these proteins, which contain only a
single saposin-like domain, were found to be comprised of
41–53% of α-helices [32–35]. Considering that proSP-BΔC
contains two saposin-like domains and a significant propor-
tion of protein (∼50%) located outside these modules, our
results are compatible with the expected secondary structure
of rproSP-BΔC. It is remarkable that both recombinant proSP-
B and recombinant proSP-BΔC were obtained as soluble
proteins in aqueous buffers whereas mature SP-B has only
been isolated and studied in organic solvents or lipidic
environments due to its high hydrophobicity. It should be also
pointed out that, according to the work of Zaltash and
Johansson [25], proSP-B is stable at 8 °C for several months
while our rproSP-BΔC has to be maintained at −80 °C for
long term storage, suggesting that the C-terminal domain
might confer stability to the recombinant protein. Zaltash and
Johansson [25] reported that proSP-B behaved in their hands
as a disulfide-dependent oligomer under non-reducing condi-
tions. Recombinant proSP-BΔC, as well as proSP-B expressed
in type II cells and in a pulmonary adenocarcinoma cell line
[36,37], was detected in the gels as a monomeric form in the
absence of any reducing agent (not shown). Nevertheless,
recombinant proSP-BΔC also exhibited a clear tendency to
form high molecular mass oligomers that did not easilypenetrate in SDS-PAGE gels. This could be at least partially
driven by formation of some intermolecular disulfides.
According to our results about 20% of the cysteines in
rproSP-BΔC might be involved in inter- or intra-molecular
disulfide bonds. Some of the intramolecular disulfides could
be responsible for the apparent changes in electrophoretic
mobility detected in the protein along the purification and
refolding procedures, as has been shown for other proteins
refolded in vitro [38,39].
On the other hand, fluorescence emission maximum of
rproSP-BΔC is dominated by the contribution of tryptophan,
centred at 333 nm, as expected for residues located in a
hydrophobic microenvironment. These results, together with the
CD data described above, suggest that refolding of rproSP-BΔC
has proceeded successfully, leading to an apparently well-folded
protein available for further biophysical and structural studies.
The unavailability of native proSP-B isolated from natural
sources makes it difficult to evaluate the extent to which rproSP-
BΔC approximates a native-like conformation after refolding.
The study of the interaction of rproSP-BΔC with membranes
has a notable interest related to the understanding of the
mechanisms governing the trafficking, assembly and processing
of SP-B precursor along the exocytic pathway of Type II
pneumocytes. To our knowledge, no data had been reported so
far on the membrane binding properties of the SP-B precursor.
Our results indicate that water-soluble rproSP-B is able to
interact with different types of phospholipid membranes, either
saturated (DPPC) or unsaturated, zwiterionic (POPC) or anionic
(POPG). The monolayer insertion experiments indicate, how-
ever, that rproSP-BΔC is not inserting very deep into DPPC:
POPG (7:3, w/w) membranes suggesting that its lipid–protein
interaction is certainly different to the deep interaction expected
for mature SP-B, which is able to insert into phospholipid layers
compressed up to pressures higher than 45 mN/m [40]. It is
possible that the chaperon-like N-terminal propeptide maintains
the whole protein in shallow association with membranes until
mature SP-B is exposed and deeperly assembled into the lipids
in lamellar bodies. We propose that some environmental factors
such as the acidification of pH [41] or the increase in Ca2+
concentration to the values probably occurring in lamellar
bodies, may be triggering factors to promote such a deeper
insertion of the mature module of SP-B, which could precede or
accompany the proteolytic maturation of the precursor. It is
therefore conceivable that interaction of the SP-B precursor
with membranes, likely in a defined orientated manner, is an
important step in the assembly of the protein along its
trafficking pathway. We believe that the rproSP-BΔC form
produced in the present study is a useful analogue to get
further insight the molecular mechanisms associated with
assembly of pulmonary surfactant under physiologically-
relevant conditions.
Acknowledgements
We are sincerely grateful to Prof. Timothy E. Weaver, from
Cincinnati Children's Hospital, who generously provided us
with several of the vectors, DNA sequences and antibodies used
1631A.G. Serrano et al. / Biochimica et Biophysica Acta 1758 (2006) 1621–1632in this work. We also thank Prof. Weaver for scientific advising
and very fruitful discussions. The authors are also indebted to
Dr. Francisco Gavilanes from the Dept. de Bioquímica y
Biología Molecular I in Universidad Complutense and Dr.
Javier Varela from Centro de Investigaciones Biológicas for
technical assistance with amino acid analysis and N-terminal
sequencing, respectively. We thank as well, Dr. Juan Pablo
Albar from Centro Nacional de Biotecnología and Dra. Ma
Luisa Hernáez from the Proteomics Facility of Universidad
Complutense for their assistance with mass spectrometry
analysis and peptide fingerprinting. Authors are also indebted
to Dr. Esther Aceituno for technical assistance with the
purification of some protein batches. This work has been
supported by grants from the Spanish Ministry of Education and
Science (BIO2003-09056 and BIO2006-03130), Community of
Madrid (PMAT-000283-0505) and European Commission
(CT04-007931 and CT04-5122219).
Appendix A. Supplementary data
Supplementary data associated with this article can be found,
in the online version, at doi:10.1016/j.bbamem.2006.07.016.
References
[1] K.R. Melton, L.L. Nesslein, M. Ikegami, J.W. Tichelaar, J.C. Clark, J.A.
Whitsett, T.E. Weaver, SP-B deficiency causes respiratory failure in
adult mice, Am. J. Physiol.: Lung Cell Mol. Physiol. 285 (2003)
L543–L549.
[2] L.L. Nesslein, K.R. Melton, M. Ikegami, C.L. Na, S.E. Wert, W.R. Rice,
J.A. Whitsett, T.E. Weaver, Partial SP-B deficiency perturbs lung
function and causes air space abnormalities, Am. J. Physiol.: Lung Cell
Mol. Physiol. 288 (2005) L1154–L1161.
[3] L.M. Nogee, G. Garnier, H.C. Dietz, L. Singer, A.M. Murphy, D.E.
deMello, H.R. Colten, A mutation in the surfactant protein B gene
responsible for fatal neonatal respiratory disease in multiple kindreds,
J. Clin. Invest. 93 (1994) 1860–1863.
[4] L.M. Nogee, S.E. Wert, S.A. Proffit, W.M. Hull, J.A. Whitsett, Allelic
heterogeneity in hereditary surfactant protein B (SP-B) deficiency, Am. J.
Respir. Crit. Care Med. 161 (2000) 973–981.
[5] A. Korimilli, L.W. Gonzales, S.H. Guttentag, Intracellular localization of
processing events in human surfactant protein B biosynthesis, J. Biol.
Chem. 275 (2000) 8672–8679.
[6] T. Ueno, S. Linder, C.L. Na, W.R. Rice, J. Johansson, T.E. Weaver,
Processing of pulmonary surfactant protein B by napsin and cathepsin H, J.
Biol. Chem. 279 (2004) 16178–16184.
[7] M.A. Oosterlaken-Dijksterhuis, M. van Eijk, L.M. van Golde, H.P.
Haagsman, Lipid mixing is mediated by the hydrophobic surfactant protein
SP-B but not by SP-C, Biochim. Biophys. Acta 1110 (1992) 45–50.
[8] F.R. Poulain, L. Allen, M.C. Williams, R.L. Hamilton, S. Hawgood,
Effects of surfactant apolipoproteins on liposome structure:
implications for tubular myelin formation, Am. J. Physiol. 262
(1992) L730–L739.
[9] F.R. Poulain, S. Nir, S. Hawgood, Kinetics of phospholipid membrane
fusion induced by surfactant apoproteins A and B, Biochim. Biophys. Acta
1278 (1996) 169–175.
[10] M.A. Ryan, X. Qi, A.G. Serrano, M. Ikegami, J. Perez-Gil, J. Johansson,
T.E. Weaver, Mapping and analysis of the lytic and fusogenic domains of
surfactant protein B, Biochemistry 44 (2005) 861–872.
[11] S. Lin, K.S. Phillips, M.R. Wilder, T.E. Weaver, Structural requirements
for intracellular transport of pulmonary surfactant protein B (SP-B),
Biochim. Biophys. Acta 1312 (1996) 177–185.
[12] S. Lin, H.T. Akinbi, J.S. Breslin, T.E. Weaver, Structural requirements fortargeting of surfactant protein B (SP-B) to secretory granules in vitro and in
vivo, J. Biol. Chem. 271 (1996) 19689–19695.
[13] H.T. Akinbi, J.S. Breslin, M. Ikegami, H.S. Iwamoto, J.C. Clark, J.A.
Whitsett, A.H. Jobe, T.E. Weaver, Rescue of SP-B knockout mice with a
truncated SP-B proprotein. Function of the C-terminal propeptide, J. Biol.
Chem. 272 (1997) 9640–9647.
[14] D. Polayes, J. Hughes, Efficient protein expression and simple purification
using the pProEx-1 system, Focus 16 (1994) 81–84.
[15] S. Sechi, B.T. Chait, Modification of cysteine residues by alkylation. A
tool in peptide mapping and protein identification, Anal. Chem. 70 (1998)
5150–5158.
[16] G.L. Ellman, A colorimetric method for determining low concentrations of
mercaptans, Arch. Biochem. Biophys. 74 (1958) 443–450.
[17] G.L. Ellman, Tissue sulfhydryl groups, Arch. Biochem. Biophys. 82
(1959) 70–77.
[18] M.L. Ruano, I. Garcia-Verdugo, E. Miguel, J. Perez-Gil, C. Casals,
Self-aggregation of surfactant protein A, Biochemistry 39 (2000)
6529–6537.
[19] N. Sreerama, R.W. Woody, Estimation of protein secondary structure from
circular dichroism spectra: comparison of CONTIN, SELCON, and
CDSSTR methods with an expanded reference set, Anal. Biochem. 287
(2000) 252–260.
[20] N. Sreerama, R.W. Woody, On the analysis of membrane protein circular
dichroism spectra, Protein Sci. 13 (2004) 100–112.
[21] E. Nuñez, X. Wei, C. Delgado, I. Rodriguez-Crespo, B. Yelamos,
J. Gomez-Gutierrez, D.L. Peterson, F. Gavilanes, Cloning,
expression, and purification of histidine-tagged preS domains of
hepatitis B virus, Protein Expr. Purif. 21 (2001) 183–191.
[22] A.G. Serrano, A. Cruz, K. Rodriguez-Capote, F. Possmayer, J. Perez-Gil,
Intrinsic structural and functional determinants within the amino acid
sequence of mature pulmonary surfactant protein SP-B, Biochemistry 44
(2005) 417–430.
[23] J.R. Lakowicz, Principles of Fluorescence Spectroscopy, Plenum Press,
New York, 1999.
[24] H. Brockman, Lipid monolayers: why use half a membrane to characterize
protein–membrane interactions? Curr. Opin. Struct. Biol. 9 (1999)
438–443.
[25] S. Zaltash, J. Johansson, Secondary structure and limited proteolysis give
experimental evidence that the precursor of pulmonary surfactant protein B
contains three saposin-like domains, FEBS Lett. 423 (1998) 1–4.
[26] H.T. Akinbi, P. Markart, R. Epaud, Z.C. Chroneos, T.E. Weaver,
Antibacterial properties of surfactant protein B in innate host defense of
the lung, (2005).
[27] S. Hawgood, Surfactant protein B: structure and function, Biol. Neonate 85
(2004) 285–289.
[28] F. Brasch, M. Ochs, T. Kahne, S. Guttentag, V. Schauer-Vukasinovic, M.
Derrick, G. Johnen, N. Kapp, K.M. Muller, J. Richter, T. Giller, S.
Hawgood, F. Buhling, Involvement of napsin A in the C- and N-terminal
processing of surfactant protein B in type-II pneumocytes of the human
lung, J. Biol. Chem. 278 (2003) 49006–49014.
[29] F. Brasch, G. Johnen, A. Winn-Brasch, S.H. Guttentag, A. Schmiedl, N.
Kapp, Y. Suzuki, K.M. Muller, J. Richter, S. Hawgood, M. Ochs,
Surfactant protein B in type II pneumocytes and intra-alveolar surfactant
forms of human lungs, Am. J. Respir. Cell Mol. Biol. 30 (2004) 449–558.
[30] X. Qi, T. Leonova, G.A. Grabowski, Functional human saposins expressed
in Escherichia coli. Evidence for binding and activation properties of
saposins C with acid beta-glucosidase, J. Biol. Chem. 269 (1994)
16746–16753.
[31] A. Holzinger, K.S. Phillips, T.E. Weaver, Single-step purification/
solubilization of recombinant proteins: application to surfactant protein
B, BioTechniques 20 (1996) 804–806 (808).
[32] M. Andersson, T. Curstedt, H. Jornvall, J. Johansson, An amphipathic
helical motif common to tumourolytic polypeptide NK-lysin and
pulmonary surfactant polypeptide SP-B, FEBS Lett. 362 (1995) 328–332.
[33] J.S. O'Brien, Y. Kishimoto, Saposin proteins: structure, function, and role
in human lysosomal storage disorders, FASEB J. 5 (1991) 301–308.
[34] J. Perez-Gil, A. Cruz, C. Casals, Solubility of hydrophobic surfactant
proteins in organic solvent/water mixtures. Structural studies on SP-B and
1632 A.G. Serrano et al. / Biochimica et Biophysica Acta 1758 (2006) 1621–1632SP-C in aqueous organic solvents and lipids, Biochim. Biophys. Acta 1168
(1993) 261–270.
[35] A.J. Waring, Y. Chen, K.F. Faull, R. Stevens, M.A. Sherman, A.L.
Fluharty, Porcine cerebroside sulfate activator (saposin B) secondary
structure: CD, FTIR, and NMR studies, Mol. Genet. Metab. 63 (1998)
14–25.
[36] S. Hawgood, D. Latham, J. Borchelt, D. Damm, T. White, B. Benson, J.R.
Wright, Cell-specific posttranslational processing of the surfactant-
associated protein SP-B, Am. J. Physiol. 264 (1993) L290–L299.
[37] M.A. O'Reilly, T.E. Weaver, T.J. Pilot-Matias, V.K. Sarin, A.F. Gazdar,
J.A. Whitsett, In vitro translation, post-translational processing and
secretion of pulmonary surfactant protein B precursors, Biochim.
Biophys. Acta 1011 (1989) 140–148.
[38] M.A. Kaderbhai, B.M. Austen, Studies on the formation of intrachaindisulphide bonds in newly biosynthesised bovine prolactin. Role of
protein-disulphide isomerase, Eur. J. Biochem. 153 (1985) 167–178.
[39] H. Lee, H.K. Kim, J.H. Lee, W.K. You, S.I. Chung, S.I. Chang, M.H. Park,
Y.K. Hong, Y.A. Joe, Disruption of interkringle disulfide bond of
plasminogen kringle 1–3 changes the lysine binding capability of
kringle 2, but not its antiangiogenic activity, Arch. Biochem. Biophys.
375 (2000) 359–363.
[40] A. Cruz, L.A. Worthman, A.G. Serrano, C. Casals, K.M. Keough, J. Perez-
Gil, Microstructure and dynamic surface properties of surfactant protein
SP-B/dipalmitoylphosphatidylcholine interfacial films spread from lipid–
protein bilayers, Eur. Biophys. J. 29 (2000) 204–213.
[41] M.F. Beers, Inhibition of cellular processing of surfactant protein C by
drugs affecting intracellular pH gradients, J. Biol. Chem. 271 (1996)
14361–14370.
